WebNov 2, 2024 · At Pfizer's current price per dose of $19.50, this represents a market of more than $370 million. However, Pfizer has indicated that it will probably charge more once the pandemic is over.... WebNov 1, 2024 · Pfizer collected revenue of $11.3 billion in the first half of the year from its COVID-19 vaccine, now known as Comirnaty, and analysts project third-quarter sales of $11.86 billion.
COVID-19 Vaccines: How Much Revenue Will Each Drugmaker Generate in 2024?
WebMar 8, 2024 · The companies expect the vaccine to bring in revenues of approximately $15 billion in 2024. Pfizer and BioNTech plan to supply up to 1.3 billion doses of the vaccine worldwide by the end of 2024. WebNov 4, 2024 · Pfizer reportedly made $36 billion from COVID-19 vaccines this year. Heading into next year, the U.S. drugmaker expects to make $29 billion from COVID-19 vaccines. Those projections could rise as Pfizer seeks to sign more deals with countries to produce vaccines. Overall, Pfizer hopes to produce four billion vaccines in 2024. flugzeug classic leserservice
Here’s what Covid vaccines are worth to Big Pharma - CNN
WebTop 10 Medicines and Vaccines Take a look at our breakdown of the top medicines and vaccines by revenue from 2024. $36,781 million Comirnaty® $5,970 million Eliquis® (apixaban) $5,437 million Ibrance® (palbociclib) $5,272 million Prevnar Family® $2,455 … WebApr 14, 2024 · How much money could Pfizer make in 2024 if it wins authorization for the vaccine in adolescents? ... It's possible that Pfizer won't make an extra penny in 2024 if BNT162b2 wins an expanded EUA ... WebTop 10 Medicines and Vaccines Take a look at our breakdown of the top medicines and vaccines by revenue from 2024. $36,781 million Comirnaty® $5,970 million Eliquis® (apixaban) $5,437 million Ibrance® (palbociclib) $5,272 million Prevnar Family® $2,455 million Xeljanz® (tofacitinib) $2,015 million Vyndaqel®/Vyndamax™ (tafamidis) $1,185 … greenery frame clipart